Biogen Surges After FDA Reviewers Support Alzheimer’s Drug - Yahoo Finance
- Biogen Surges After FDA Reviewers Support Alzheimer’s Drug Yahoo Finance
- Biogen's stock jumps 42% after FDA staff says it has enough data to support approving Alzheimer's drug CNBC
- Biogen Alzheimer's drug closer to approval Reuters
- Biogen shares leap after ‘substantial evidence’ Alzheimer’s drug is effective Financial Times
- Ahead of crucial meeting, Biogen’s Alzheimer’s drug wins praise from the FDA BetaBoston
- View Full Coverage on Google News